Quest PharmaTech Inc., a pharmaceutical company, develops targeted cancer therapies in Canada. Its lead product is MAb AR9.6, a theranostic agent for cancer in preclinical development for pancreatic cancer. The company is headquartered in E…
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Results 2026-05-30
Annual MD&A - English.pdf
Results 2026-05-30
Audited annual financial statements – English.pdf
News 2026-05-29
News release - English.pdf
Transactions 2026-05-11 Financing
Other material contracts - English.pdf
Transactions 2026-05-11 Financing
Other material contracts - English.pdf
Transactions 2026-05-11 Financing
Other material contracts - English.pdf
Transactions 2026-05-11 Financing
Other material contracts - English.pdf
Results 2025-12-22 Financials
Interim MD&A - English.pdf
Results 2025-12-22 Financials
Interim financial statements/report – English.pdf
Results 2025-09-26 Financials
Interim MD&A - English.pdf
Results 2025-09-26 Financials
Interim financial statements/report – English.pdf
News 2025-08-27
News release - English.pdf